Form 4 for CALC CalciMedica, Inc.

Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0001415889-24-023226 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-09-11	2024-09-09	CALC	Dunn Michael J.	Pres, COO	M - OptEx	$1.39	+11.8K	11.8K	New	+$16.3K
D	2024-09-11	2024-09-09	CALC	Dunn Michael J.	Pres, COO	M - OptEx	—	-11.8K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-09-09	M	A	11,761	$1.39	11,761	D	—	—
2	Derivative	Employee Stock Option (Right to Buy)	2024-09-09	M	D	11,761	—	0	D	$1.39 · — to 2024-10-01	11,761 Common Stock	(F2) Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer (formerly known as Graybug Vision, Inc.) and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. (F1) Immediately exercisable.